Clinical Trial Update: Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection [Phase 3]

View source ↗

Summary

Phase 3 study evaluating hyperpolarized xenon MRI to assess pulmonary function after lung resection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Resection Complications
• Pulmonary Disease
• Pulmonary Surgical Procedures

Drugs mentioned

• Hyperpolarized xenon MRI

Snippet

Sponsor: Polarean, Inc. | Conditions: Pulmonary Surgical Procedures | Phase 3 | Status: COMPLETED | Results posted: 2022-06-28